# Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer

> **NCT03724994** · — · COMPLETED · sponsor: **Lund University** · enrollment: 201 (actual)

## Conditions studied

- Periampullary Adenocarcinoma
- Periampullary Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT03724994
- **Lead sponsor:** Lund University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03724994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03724994, "Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03724994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*